Conventional Versus Natural Alternative Treatments for Leishmaniasis: A Review

Carregando...
Imagem de Miniatura
Citações na Scopus
27
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
BENTHAM SCIENCE PUBL LTD
Autores
PASSERO, Luiz Felipe Domingues
CRUZ, Lucas Antal
SANTOS-GOMES, Gabriela
RODRIGUES, Eliana
LAGO, Joao Henrique Ghilardi
Citação
CURRENT TOPICS IN MEDICINAL CHEMISTRY, v.18, n.15, p.1275-1286, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Leishmaniasis is a neglected disease caused by protozoan belonging to the Leishmania genus. There are at least 16 pathogenic species for humans that are able to cause different clinical forms, such as cutaneous or visceral leishmaniasis. In spite of the different species and clinical forms, the treatment is performed with few drug options that, in most cases, are considered outdated. In addition, patients under classical treatment show serious side effects during drug administration, moreover parasites are able to become resistant to medicines. Thus, it is believed and well accepted that is urgent and necessary to develop new therapeutic options to overpass these concerns about conventional therapy of leishmaniasis. The present review will focus on the efficacy, side effects and action mechanism of classic drugs used in the treatment of leishmaniasis, as well as the importance of traditional knowledge for directing a rational search toward the discovery and characterization of new and effective molecules (in vivo assays) from plants to be used against leishmaniasis.
Palavras-chave
Leishmaniasis, Conventional drugs, Ethnopharmacology, New drugs, Molecules, Amphotericin
Referências
  1. Saltos RVA, 2016, ACTA AMAZON, V46, P355, DOI 10.1590/1809-4392201600305
  2. Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7
  3. BALICK MJ, 1990, CIBA F SYMP, V154, P22
  4. Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1768-1797.2006, 10.1128/AAC.50.5.1788-1797.2006]
  5. BERMAN JD, 1985, ANTIMICROB AGENTS CH, V27, P916, DOI 10.1128/AAC.27.6.916
  6. BERMAN JD, 1987, BIOCHEM PHARMACOL, V36, P197
  7. Bezerra-Souza A, 2016, PARASITOL INT, V65, P702, DOI 10.1016/j.parint.2016.08.003
  8. Bourdy G, 2000, J ETHNOPHARMACOL, V70, P87, DOI 10.1016/S0378-8741(99)00158-0
  9. BRITTAIN HG, 1994, CHIRALITY, V6, P665, DOI 10.1002/chir.530060811
  10. Campos BLS, 2015, PARASITE IMMUNOL, V37, P407, DOI 10.1111/pim.12206
  11. Carvalho AK, 2016, MEDIAT INFLAMM, DOI 10.1155/2016/7068287
  12. Carvalho AK, 2012, PARASITE IMMUNOL, V34, P395, DOI 10.1111/j.1365-3024.2012.01370.x
  13. Celine V, 2009, J ETHNOPHARMACOL, V123, P413, DOI 10.1016/j.jep.2009.03.041
  14. Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748
  15. Chaudhari MB, 2016, DRUG DELIV TRANSL RE, V6, P354, DOI 10.1007/s13346-015-0267-6
  16. Chawla B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026660
  17. Cole A. C. E., 1944, TRANS ROY SOC TROP MED AND HYG, V37, P409, DOI 10.1016/S0035-9203(44)90022-2
  18. Rubiano LC, 2012, J INFECT DIS, V205, P684, DOI 10.1093/infdis/jir816
  19. Corpas-Lopez V, 2015, J NAT PROD, V78, P1202, DOI 10.1021/np5008697
  20. Bieski IGC, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/272749
  21. Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008
  22. Cristina G. C. G, 1915, PATHOLOGICA, V7, P82
  23. Cruz ED, 2013, PHYTOCHEMISTRY, V89, P71, DOI 10.1016/j.phytochem.2013.01.014
  24. CUNNINGHAM ML, 1995, EUR J BIOCHEM, V230, P460
  25. Dal Picolo CR, 2014, FITOTERAPIA, V97, P28, DOI 10.1016/j.fitote.2014.05.009
  26. de Mesquita ML, 2005, MEM I OSWALDO CRUZ, V100, P783, DOI 10.1590/S0074-02762005000700019
  27. Decuypere S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001514
  28. Denton H, 2004, BIOCHEM J, V381, P405, DOI 10.1042/BJ20040283
  29. Devlin RK, 2005, INFECT DIS CLIN PRAC, V13, P84
  30. Passero LFD, 2009, PARASITOL RES, V105, P1741, DOI 10.1007/s00436-009-1614-7
  31. Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275
  32. Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111
  33. Ferreira ME, 2010, PHYTOMEDICINE, V17, P375, DOI 10.1016/j.phymed.2009.09.009
  34. Ephros M, 1999, ANTIMICROB AGENTS CH, V43, P278, DOI 10.1128/AAC.43.2.278
  35. Estevez Y, 2007, J ETHNOPHARMACOL, V114, P254, DOI 10.1016/j.jep.2007.08.007
  36. Ferreira ME, 2002, J ETHNOPHARMACOL, V80, P199, DOI 10.1016/S0378-8741(02)00025-9
  37. FOURNET A, 1994, J ETHNOPHARMACOL, V41, P19, DOI 10.1016/0378-8741(94)90054-X
  38. FOURNET A, 1994, PLANTA MED, V60, P8, DOI 10.1055/s-2006-959397
  39. FOURNET A, 1992, TROP MED PARASITOL, V43, P219
  40. Franca F, 1996, Rev Soc Bras Med Trop, V29, P229
  41. Franca F, 1993, Rev Soc Bras Med Trop, V26, P151
  42. Gachet MS, 2009, J ETHNOPHARMACOL, V121, P14, DOI 10.1016/j.jep.2008.10.015
  43. Gainey D, 1996, J CELL PHYSIOL, V168, P248, DOI 10.1002/(SICI)1097-4652(199608)168:2<248::AID-JCP3>3.0.CO;2-P
  44. Garcia M, 2011, FORSCH KOMPLEMENTMED, V18, P351, DOI 10.1159/000335280
  45. de Lima SCG, 2014, BIOMED RES INT, DOI 10.1155/2014/848293
  46. Hailu T, 2016, J VECTOR DIS, V53, P193
  47. Haldar Arun Kumar, 2011, Mol Biol Int, V2011, P571242, DOI 10.4061/2011/571242
  48. Hermoso A, 2003, BIOORGAN MED CHEM, V11, P3975, DOI 10.1016/S0968-0896(03)00406-1
  49. Holmstedt B. R., 1995, ETHNOBOTANY EVOLUTIO, P416
  50. Imbert L, 2012, ANAL BIOANAL CHEM, V402, P1169, DOI 10.1007/s00216-011-5520-3
  51. Jesus JA, 2017, INT J PARASITOL-DRUG, V7, P1, DOI 10.1016/j.ijpddr.2016.12.002
  52. JHA TK, 1983, T ROY SOC TROP MED H, V77, P167, DOI 10.1016/0035-9203(83)90058-5
  53. Kate K. T., 1999, COMMERCIAL USE BIODI, P398
  54. Khaliq T, 2009, BIOORG MED CHEM LETT, V19, P2585, DOI 10.1016/j.bmcl.2009.03.039
  55. KINGSTON DGI, 1977, J PHARM SCI, V66, P1135, DOI 10.1002/jps.2600660821
  56. Kvist LR, 2006, J ETHNOPHARMACOL, V106, P390, DOI 10.1016/j.jep.2006.01.020
  57. Laurenti MD, 2014, BIOMED RES INT, DOI 10.1155/2014/134236
  58. Lopes MV, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/298320
  59. Lucas CM, 1998, AM J TROP MED HYG, V59, P312, DOI 10.4269/ajtmh.1998.59.312
  60. de Oliveira ARM, 2009, QUIM NOVA, V32, P1971, DOI 10.1590/S0100-40422009000700048
  61. MARR JJ, 1991, J LAB CLIN MED, V118, P111
  62. Masmoudi A, 2013, J DERMATOL CASE REP, V7, P31, DOI 10.3315/jdcr.2013.1135
  63. MEGO JL, 1985, BIOCHIM BIOPHYS ACTA, V841, P139, DOI 10.1016/0304-4165(85)90014-5
  64. Mittal MK, 2007, AM J TROP MED HYG, V76, P681, DOI 10.4269/ajtmh.2007.76.681
  65. Monzote L, 2014, PHYTOMEDICINE, V21, P1048, DOI 10.1016/j.phymed.2014.03.002
  66. Monzote L, 2006, CHEMOTHERAPY, V52, P130, DOI 10.1159/000092858
  67. Monzote L, 2014, PHYTOTHER RES, V28, P753, DOI 10.1002/ptr.5055
  68. Muganza DM, 2012, J ETHNOPHARMACOL, V141, P301, DOI 10.1016/j.jep.2012.02.035
  69. MURRAY HW, 1988, J INFECT DIS, V158, P1372, DOI 10.1093/infdis/158.6.1372
  70. Odonne G, 2011, J ETHNOPHARMACOL, V137, P1228, DOI 10.1016/j.jep.2011.07.044
  71. Okpekon T, 2004, J ETHNOPHARMACOL, V90, P91, DOI 10.1016/j.jep.2003.09.029
  72. Passero LFD, 2007, PARASITOL RES, V101, P677, DOI 10.1007/s00436-007-0530-y
  73. Passero L. F. D., 2012, CURR CLIN PHARM, V9, P187
  74. Passero LFD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-64
  75. Passero LFD, 2008, PARASITOL RES, V102, P1025, DOI 10.1007/s00436-007-0871-6
  76. Passero LFD, 2012, ARCH DERMATOL RES, V304, P47, DOI 10.1007/s00403-011-1171-7
  77. PETERS W, 1981, INDIAN J MED RES, V73, P1
  78. Ramos H, 1996, J MEMBRANE BIOL, V152, P65, DOI 10.1007/s002329900086
  79. Ramos PK, 2016, BIOMED RES INT, DOI 10.1155/2016/6937980
  80. Ribeiro TG, 2014, EXP PARASITOL, V143, P60, DOI 10.1016/j.exppara.2014.05.004
  81. Rijal S, 2007, MICROBES INFECT, V9, P529, DOI 10.1016/j.micinf.2007.01.009
  82. Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102
  83. ROBERTS WL, 1995, ANTIMICROB AGENTS CH, V39, P1234, DOI 10.1128/AAC.39.6.1234
  84. Rodrigues E, 2006, PHYTOTHER RES, V20, P378, DOI 10.1002/ptr.1866
  85. Rodrigues E, 2012, J ETHNOPHARMACOL, V144, P806, DOI 10.1016/j.jep.2012.10.026
  86. Rodrigues E, 2007, J ETHNOPHARMACOL, V111, P295, DOI 10.1016/j.jep.2006.11.017
  87. Rodrigues IA, 2014, BIOMED RES INT, DOI 10.1155/2014/985171
  88. Sampaio R. N. R, REV SOC BRAS MED TRO, V36, P531
  89. Schmidt TJ, 2012, CURR MED CHEM, V19, P2128
  90. Schmidt TJ, 2012, CURR MED CHEM, V19, P2176
  91. Scorza BM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061296
  92. Serrano DR, 2015, MOL PHARMACEUT, V12, P420, DOI 10.1021/mp500527x
  93. Silveira FT, 2009, PARASITE IMMUNOL, V31, P423, DOI 10.1111/j.1365-3024.2009.01116.x
  94. Soto J, 2009, AM J TROP MED HYG, V81, P387, DOI 10.4269/ajtmh.2009.81.387
  95. Srivastava S, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1969-z
  96. Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x
  97. Sundar Shyam, 2007, Ther Clin Risk Manag, V3, P733
  98. Thakur CP, 2000, T ROY SOC TROP MED H, V94, P696, DOI 10.1016/S0035-9203(00)90238-4
  99. Ullah N, 2016, PHYTOTHER RES, V30, P1905, DOI 10.1002/ptr.5710
  100. VAZQUEZ M L, 1991, Boletin de la Oficina Sanitaria Panamericana, V110, P402
  101. Velez I, 2010, AM J TROP MED HYG, V83, P351, DOI 10.4269/ajtmh.2010.10-0060
  102. Verdi LG, 2005, QUIM NOVA, V28, P85, DOI 10.1590/S0100-40422005000100017
  103. Vianna G, 1912, P AN 7 C BRAS MED CI, P428
  104. Vincent IM, 2014, INT J PARASITOL-DRUG, V4, P20, DOI 10.1016/j.ijpddr.2013.11.002
  105. Wasan EK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000913
  106. Weniger B, 2001, J ETHNOPHARMACOL, V78, P193, DOI 10.1016/S0378-8741(01)00346-4
  107. Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200
  108. Yamamoto E. S, 2015, PLOS ONE, V10, P1, DOI 10.1371/J0URNAL.P0NE.0144946
  109. Zalewski CA, 2011, PHARM BIOL, V49, P602, DOI 10.3109/13880209.2010.537828
  110. Zhou Y, 2004, J BIOL CHEM, V279, P37445, DOI 10.1074/jbc.M404383200
  111. Zufferey R, 2002, MOL BIOCHEM PARASIT, V125, P127, DOI 10.1016/S0166-6851(02)00220-7